We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.40
Bid: 322.40
Ask: 322.80
Change: -3.60 (-1.11%)
Spread: 0.40 (0.124%)
Open: 329.60
High: 329.60
Low: 319.40
Prev. Close: 323.00
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Mar 2021 15:30

RNS Number : 6874R
Rotork PLC
09 March 2021
 

 

9 March 2021

 

Rotork plc

 ("Company")

 

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

 

The Company provides notification of the following transactions, all effected on 8 March 2021 outside of a market venue, relating to the two below named Executive Directors as PDMRs and their respective interests in the ordinary share capital of the Company ("Shares") (ISIN: GB00BVFNZH21).

 

The transactions arise from: (i) the conditional award of Shares granted to Kevin Hostetler and Jonathan Davis under the Company's Deferred Annual Bonus Plan 2018 ("DABP") relating to the three-year deferred element of their respective 2020 annual bonus, and (ii) the exercise and immediate dealing by Jonathan Davis of a fully vested nil cost option award over certain Shares granted to him on 7 March 2018 under the Company's DABP relating to the three-year deferred element of his 2017 annual bonus.

 

Individual PDMR details are set out in the table below:

 

Name and position of PDMR

No. of conditional award Shares granted on 8 March 2021 as per (i) above ¹ ²

 

No. of Shares acquired on exercise, sold and retained on 8 March 2021 as per (ii) above

Kevin Hostetler,

Chief Executive

 

18,533

N/A

Jonathan Davis,

Group Finance Director

 

8,544

15,438 Shares acquired ³ (including dividend equivalent) 7,231 Shares sold at 365.20p per share

8,207 Shares retained

 

 

¹ Recovery and Withholding apply to the conditional award Shares granted under the DABP for three-years from the date of grant, including post cessation of employment. A dividend equivalent entitlement also attaches to the Shares.

² The amount of the 2020 annual bonus being deferred for Messrs. Hostetler and Davis is £67,685 (12.9%) and £31,203 (12.9%) respectively. The number of conditional award Shares were determined based on a share price of 365.20p, being the MMQ of a Rotork share on the business day immediately preceding the date of grant, ie on 5 March 2021 ("Strike Price").

³ The Shares acquired on exercise were existing market purchased Shares delivered from the Company's Employee Benefit Trust ("EBT").

The Shares sold were to cover Jonathan Davis' immediate personal income tax and social security liability arising on exercise. The Shares sold were purchased by the EBT at the Strike Price.

The Shares retained are held in the name of Jonathan Davis' spouse, a Person Closely Associated with him as defined under the EU Market Abuse Regulation ("MAR").

 

Full details relating to: (a) the 2020 annual bonus outturns for the Executive Directors and the corresponding 2021 DABP conditional Shares award to them, and (b) the 2018 DABP Shares vesting to Jonathan Davis, will appear in the Directors' Remuneration Report to the Company's 2020 Annual Report due to be published on 30 March 2021.

 

The Company can confirm that each of the above named PDMRs have complied with their respective obligation to notify the Financial Conduct Authority of the above transactions as required under MAR.

 

- END -

 

Rotork contact and telephone number for enquiries:

Sandra Forbes, Group General Counsel & Company Secretary (Interim)

++44 (0) 7775 703 579

 

Notes:

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXSSGDGBC
Date   Source Headline
2nd May 20245:53 pmRNSTransaction in Own Shares
1st May 20246:09 pmRNSTransaction in Own Shares
1st May 202412:45 pmRNSTotal Voting Rights
1st May 20249:00 amRNSBoard Committee Composition
30th Apr 20246:07 pmRNSTransaction in Own Shares
30th Apr 20243:20 pmRNSResult of AGM
30th Apr 20247:00 amRNSTrading Update
29th Apr 20246:05 pmRNSTransaction in Own Shares
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20245:47 pmRNSTransaction in Own Shares
24th Apr 20246:20 pmRNSTransaction in Own Shares
23rd Apr 20246:03 pmRNSTransaction in Own Shares
23rd Apr 202411:00 amRNSHolding(s) in Company
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:37 pmRNSTransaction in Own Shares
18th Apr 20246:09 pmRNSTransaction in Own Shares
18th Apr 20244:18 pmRNSDirector/PDMR Shareholding
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:13 pmRNSTransaction in Own Shares
15th Apr 20246:00 pmRNSTransaction in Own Shares
12th Apr 20245:53 pmRNSTransaction in Own Shares
12th Apr 20242:00 pmRNSDirector/PDMR Shareholding
11th Apr 20245:39 pmRNSTransaction in Own Shares
11th Apr 20244:59 pmRNSDirector/PDMR Shareholding
10th Apr 20246:04 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
9th Apr 20243:30 pmRNSDirector/PDMR Shareholding
8th Apr 20246:04 pmRNSTransaction in Own Shares
4th Apr 20246:07 pmRNSTransaction in Own Shares
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
2nd Apr 20244:15 pmRNSTotal Voting Rights
2nd Apr 20243:00 pmRNSDirector/PDMR Shareholding
28th Mar 20245:46 pmRNSTransaction in Own Shares
27th Mar 20246:09 pmRNSTransaction in Own Shares
26th Mar 20245:55 pmRNSTransaction in Own Shares
26th Mar 20245:28 pmRNSDirector/PDMR Shareholding
26th Mar 20242:18 pmRNS2023 Annual Report and Notice of 2024 AGM
25th Mar 20245:35 pmRNSTransaction in Own Shares
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
22nd Mar 20245:51 pmRNSTransaction in Own Shares
21st Mar 20246:17 pmRNSTransaction in Own Shares
21st Mar 20247:00 amRNSShare Buy-Back Programme
19th Mar 202410:30 amRNSHolding(s) in Company
12th Mar 20244:00 pmRNSDirector/PDMR Shareholding
11th Mar 20243:29 pmRNSDirector/PDMR Shareholding
5th Mar 20247:01 amRNSShare buy-back programme
5th Mar 20247:00 amRNS2023 Preliminary Results
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.